Statistics about Health, Pharma & Medtech in Japan
Statistics
- Number of mental health consultations over telephone Japan FY 2013-2022
- Number of patients with mental disorders per 100,000 inhabitants Japan 1996-2020
- Number of mental health consultations Japan FY 2022, by contact method
- Consultation cases on psychological child abuse Japan FY 2012-2021
- Share of office workers feeling mentally unstable amid COVID-19 Japan 2021
- Number of mental health and welfare consultations Japan FY 2022, by reason
- Number of patients with Alzheimer's Japan 1996-2020, by gender
- Share of establishments implementing measures for mental health Japan 2022, by size
- Estimated amount of blood donations Japan 2013-2021
- Number of blood donations Japan 2021, by type of donation
- Alfresa's net sales FY 2013-2022
- Taisho Pharmaceutical's female manager share FY 2013-2020
- Alfresa's ethical pharma wholesale business net sales FY 2014-2018
- Estimated amount of blood donations Japan 2021, by type
- Taisho Pharmaceutical's net sales FY 2012-2021
- Number of blood donors Japan 2021, by age group
- Japanese Red Cross's revenue from blood services FY 2016-2019
- Number of blood donors Japan 2021, by gender
- Alfresa's manufacturing business net sales FY 2014-2018
- Alfresa's net sales FY 2017, by segment
- Alfresa's ethical pharma wholesaling business sales FY 2020, by product category
- Taisho Pharmaceutical's gross profit FY 2013-2021
- Distribution of blood donors Japan 2021, by donation site
- Alfresa's market capitalization FY 2013-2017
- Alfresa's medical-related business net sales FY 2015-2018
- Alfresa's operating profit FY 2013-2018
- Japanese Red Cross's revenue from blood services FY 2021, by segment
- Japanese Red Cross's expenditure on blood services FY 2021, by segment
- Alfresa's self-medication product wholesale business sales FY 2020, by product
- Alfresa's female manager rate FY 2015-2017
- Alfresa's operating profit FY 2017, by segment
- Alfresa's employee numbers FY 2015-2017
- Alfresa's self-medication products wholesale business net sales FY 2014-2018
- Import value of medical products to Japan 2012-2021
- Number of life sciences PCT applications in Japan by area 2009-2012
- Level of experience with drugs among teenagers Japan 2023
- Taisho Pharmaceutical's net income FY 2013-2020
- Taisho Pharmaceutical's employee number FY 2013-2020
- Taisho Pharmaceutical's total assets FY 2013-2020
- Alfresa's manufacturing business sales FY 2017, by field
- Taisho Pharmaceutical's operating profit FY 2013 to 2018
- Annual growth rate of pharmaceutical spending in Japan FY 2018-2024
- Japanese Red Cross's expenditure on blood services FY 2016-2019
- Alfresa's net income FY 2013-2017
- Pharmaceutical spending Japan FY 2018-2024
- Number of medical errors reported to JQ Japan 2013-2022, by report type
- Taisho Pharmaceutical's R&D expenditures FY 2013-2020
- Number of blood donors Japan 2013-2021
- Antipyretic analgesics domestic shipment value in Japan 2010-2019
- Drug production value share of digestive organ agents Japan 2018, by category
- Production value of pharmaceuticals Japan 2021, by prefecture
- Production value of medical drugs Japan 2021, by production place
- Designated quasi drugs market shipment value in Japan 2010-2019
- Production value of antimetabolites Japan 2019-2022
- Pharmaceutical drug production value Japan 2018, by prefecture
- Wholesale value of pharmaceuticals Japan FY 2022, by category
- Drug production value of sensory organ agents Japan 2016, by category
- Production value of antitumor plant component preparation Japan 2019-2022
- OTC drugs wholesale value in Japan FY 1990-2021
- Production value of metabolic drugs Japan 2019-2022
- Production value of metabolic drugs Japan 2022, by type
- Share of drug production value Japan 2013-2022, by type
- Production value of central nervous system drugs Japan 2019-2022
- Drug production value share of antibiotics Japan 2016, by category
- Production value of drugs for blood and body fluids Japan 2019-2022
- Pharma sales value of manufacturers and sellers Japan FY 2022, by sales region
- Sales value of leading ethical drugs Japan FY 2022
- eHealth market revenue in Japan 2019-2028, by segment
- Production value of biological products Japan 2021, by type
- Preferred frequency of taking Chinese herbal medicine Japan 2023
- Median approval time of new drugs Japan 2003-2022, by type
- Share of the volume of generics in the prescription drug market Japan 2011-2023
- Share of prescription and OTC drug in wholesale Japan FY 2013-2022
- Wholesale value of pharmaceuticals Japan FY 2015-2022
- Share of seniors who faced mistakes purchasing health supplements Japan 2023
- Drug production value share of hormones Japan 2021, by category
- Frequency of senior Japanese people taking health supplements Japan 2023
- Drug production value share of vitamins Japan 2019, by category
- Drug production value of digestive organ agents Japan 2016, by category
- Number of BTC and OTC drugs approved by PMDA Japan FY 2013-2022
- Share of clinical trials in selected countries APAC 1999-2022, by participants
- Number of pharmaceutical products approved by PMDA Japan FY 2022, by type
- Most common reasons to take Chinese medicine for young people Japan 2023
- Drug production value of allergic agents Japan 2016, by category
- Share of young people who have taken Chinese medicine Japan 2023
- Share of prescription drug sales Japan FY 2013-2022, by channel
- Production value of biological products Japan 2019-2021
- Production value of central nervous system drugs Japan 2022, by type
- Revenue in the pharmaceuticals market Japan 2017-2028
- Revenue in the hand sanitizer segment Japan 2018-2029
- OTC drugs market share in Japan 2015 by product
- Drug production value of cardiovascular agents Japan 2022, by category
- Production value of oncology drugs Japan 2021, by type
- Non-prescription drugs market shipment value in Japan 2010-2019
- Revenue in the vitamins & minerals segment Japan 2018-2029
- Number of NME approved Japan 2013-2022
- Revenue in the Pharmaceuticals market Japan 2017-2028
- Total revenue of Perjeta 2018-2022, by region
- Number of quasi-drugs approved by PMDA Japan FY 2013-2022
- Usage volume influenza vaccination Japan 2013-2022